Cargando…
EGFR基因突变与肺腺癌主要病理分型及标本类型的关系
BACKGROUND AND OBJECTIVE: With the development of genetic mutations and targeted drugs, accurate therapy of lung adenocarcinoma attracts much more attention, and more research is focued on epidermal growth factor receptor (EGFR). It is unclear whether the result of EGFR mutation and pathology type i...
| Formato: | Online Artículo Texto |
|---|---|
| Lenguaje: | English |
| Publicado: |
中国肺癌杂志编辑部
2017
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5973361/ https://www.ncbi.nlm.nih.gov/pubmed/28641695 http://dx.doi.org/10.3779/j.issn.1009-3419.2017.06.03 |